One of the two California doctors involved in the investigation into the overdose death of actor Matthew Perry is expected to plead guilty to charges related to the surgical anaesthetic ketamine, as per the Hollywood Reporter.
The information was confirmed by a Department of Justice official on Friday, according to The Hollywood Reporter.
Mark Chavez, 54, appeared in a Los Angeles federal court on Friday for a bond hearing and arraignment.
According to Ciaran McEvoy from the United States Attorneys' Office, Chavez is expected to enter a guilty plea in the coming weeks. His plea will be the third in the ongoing investigation into Perry's death.
The 'Friends' actor was found dead in October in the hot tub at his Pacific Palisades home.
According to The Hollywood Reporter, the investigation into Perry's death has led to the arrest of five people. These include Chavez, Perry's assistant Kenneth Iwamasa, another doctor named Salvador Plasencia, a drug dealer, and a woman known as the "ketamine queen."
Jasveen Sangha, the woman dubbed the "ketamine queen," and Salvador were identified as the lead defendants in this case.
The Los Angeles County Medical Examiner's Office reported that Perry died from the acute effects of ketamine, which led to cardiovascular overstimulation and respiratory depression.
The amount of ketamine found in Perry's blood was comparable to what is used during general anaesthesia. The medical examiner also noted that drowning, coronary artery disease, and the effects of buprenorphine, a drug used to treat opioid addiction, were contributing factors in Perry's death.
Chavez is also accused of using a fake prescription and making false statements to a wholesale ketamine distributor.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)